4//SEC Filing
Mehta Vimal 4
Accession 0001104659-26-000835
CIK 0001720893other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 8:00 PM ET
Size
6.0 KB
Accession
0001104659-26-000835
Insider Transaction Report
Form 4
Mehta Vimal
DirectorCEO and President
Transactions
- Award
Restricted Stock Units
2026-01-01+199,032→ 200,783 total→ Common Stock (199,032 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On January 1, 2026, the Reporting Person was granted 199,032 RSUs, vesting as to 25% of the underlying shares on the six-month anniversary of the original promise date of November 4, 2025 (the "Vesting Commencement Date"), with the remaining 75% vesting in three equal installments of 25% on the last day of each subsequent six-month period thereafter, such that the RSUs are fully vested on the two-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
Documents
Issuer
BioXcel Therapeutics, Inc.
CIK 0001720893
Entity typeother
Related Parties
1- filerCIK 0001733369
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 8:00 PM ET
- Size
- 6.0 KB